Timing of androgen-deprivation therapy in prostate cancer

Lancet Oncol. 2017 Nov;18(11):e634. doi: 10.1016/S1470-2045(17)30775-1. Epub 2017 Oct 31.

Author

Lakshminarayanan Nandagopal¹

Affiliation

¹ University of Alabama at Birmingham, Birmingham, 35294 AL, USA. Electronic address: [email protected].

PMID: 29208388
DOI: 10.1016/S1470-2045(17)30775-1

No abstract available

Publication types

Letter
Comment

MeSH terms

Androgen Antagonists*
Humans
Male
Prostatic Neoplasms*

Substances

Androgen Antagonists